Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 9/20 | 0.66 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | GRM8 | O00222 | 1/20 | 0.53 |
| ▸ | GRM6 | O15303 | 1/20 | 0.53 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25334353 | 1.00 | LTA4H (0.66) | LTA4HMEN1KMT2AMAPTHPGD | |
| Iodide SCHEMBL10947428 | 0.99 | LTA4H (0.64) | LTA4HMEN1KMT2AMAPTHPGD | |
| Hydrochloric Acid SCHEMBL10950909 | 0.99 | LTA4H (0.64) | LTA4HMEN1KMT2AMAPTHPGD | |
| Hydrochloric Acid SCHEMBL25433519 | 0.99 | LTA4H (0.64) | LTA4HMEN1KMT2AMAPTHPGD | |
| Water SCHEMBL6282450 | 0.99 | LTA4H (0.64) | LTA4HMEN1KMT2AMAPTHPGD | |
| Water SCHEMBL28456938 | 0.99 | LTA4H (0.64) | LTA4HMEN1KMT2AMAPTHPGD | |
| Bromide SCHEMBL10946982 | 0.99 | LTA4H (0.64) | LTA4HMEN1KMT2AMAPTHPGD | |
| SCHEMBL10776901 | 0.93 | LTA4H (0.57) | LTA4HMEN1KMT2AMAPTHPGD | |
| SCHEMBL10776885 | 0.93 | LTA4H (0.57) | LTA4HMEN1KMT2AMAPTHPGD | |
| SCHEMBL5696921 | 0.89 | LTA4H (0.60) | LTA4HMEN1KMT2AMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 347 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023143608-A1 | COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF | 上海复东生物医药有限责任公司 | 2023-08-03 | — | — | WO | claimed |
| CN-116510024-A | Composition, preparation method and application thereof | 上海复东生物医药有限责任公司 | 2023-08-01 | — | — | CN | claimed |
| US-20230220387-A1 | D-SERINE TRANSPORT MODIFIER AND SCREENING METHOD THEREOF, AND SCREENING METHOD OF D-SERINE TRANSPORTER PROTEIN | KAGAMI INC. (JP) | 2023-07-13 | — | — | US | claimed |
| CN-112608977-B | Gamma-glutamyl transpeptidase detection kit and detection method thereof | 武汉伊莱瑞特生物科技股份有限公司 | 2022-05-10 | — | — | CN | claimed |
| EP-3760197-B1 | TRANSPORT PROTEIN INHIBITOR FOR REDUCING EXPRESSION OF PD-1 | INST BASIC MEDICAL SCIENCES CAMS (CN) | 2022-04-27 | — | — | EP | claimed |
| US-20210283100-A1 | ASCORBIC ACID, QUINONE COMPOUND, AND SODIUM GLUCOSE COTRANSPORTER INHIBITOR FOR TREATING CANCER | IC MEDTECH CORP (US) | 2021-09-16 | — | — | US | claimed |
| WO-2021132691-A1 | D-SERINE TRANSPORT MODIFIER AND SCREENING METHOD THEREOF, AND SCREENING METHOD OF D-SERINE TRANSPORTER PROTEIN | KAGAMI株式会社 | 2021-07-01 | — | — | WO | claimed |
| CN-112608977-A | Gamma-glutamyl transpeptidase detection kit and detection method thereof | 武汉伊莱瑞特生物科技股份有限公司 | 2021-04-06 | — | — | CN | claimed |
| EP-3490543-A1 | ASCORBIC ACID, QUINONE COMPOUND, AND SODIUM GLUCOSE COTRANSPORTER INHIBITOR FOR TREATING CANCER | IC-Medtech Corp. (US) | 2019-06-05 | — | — | EP | claimed |
| US-10082510-B2 | SRC-2 use as metabolic biomarker for diagnosis and treatment of metastatic prostate cancer | BAYLOR COLLEGE OF MEDICINE (US) | 2018-09-25 | — | — | US | claimed |
| US-4851572-A | DIAGNOSIS OF LIVER AND BILE DUCT DISORDERS, ALCOHOLISM | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-25 | — | — | US | claimed |
| EP-0297607-A1 | Gamma-L-glutamyl-4-nitroanilide derivatives and process for determining gamma-GTP activity using the same | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1989-01-04 | — | — | EP | claimed |
| US-4567138-A | Method for determining γ-glutamyltransferase activity and kits containing a novel substrate solution for use therein | BECKMAN INSTRUMENTS, INC. (US) | 1986-01-28 | — | — | US | claimed |
| US-4511651-A | Reagent composition and assay for the determination of γ-glutamyltransferase activity | AMERICAN MONITOR CORPORATION (US) | 1985-04-16 | — | — | US | claimed |
| EP-0118534-A1 | METHOD FOR DETERMINING -g(g)-GLUTAMYLTRANSFERASE ACTIVITY AND KITS CONTAINING A NOVEL SUBSTRATE SOLUTION FOR USE THEREIN. | BECKMAN INSTRUMENTS INC (US) | 1984-09-19 | — | — | EP | claimed |
| WO-1984000978-A1 | METHOD FOR DETERMINING gamma-GLUTAMYLTRANSFERASE ACTIVITY AND KITS CONTAINING A NOVEL SUBSTRATE SOLUTION FOR USE THEREIN | BECKMAN INSTRUMENTS INC (US) | 1984-03-15 | — | — | WO | claimed |
| US-4372874-A | Stabilization of hydrolysis prone labile organic reagents in liquid media | MEDICAL ANALYSIS SYSTEMS, INC. | 1983-02-08 | — | — | US | claimed |
| US-4049702-A | DIAGNOSIS OF LIVER DISEASE BY DETERMINATION OF G-GLUTAMYL-TRANS-PEPTIDASE | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1977-09-20 | — | — | US | claimed |
| US-3986931-A | γ-GLUTAMYL-4-NITROANILIDE COMPOUNDS AND THEIR USE IN DETERMINING γ-GLUTAMYL TRANSPEPTIDASE | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1976-10-19 | — | — | US | claimed |
| US-3979447-A | DETERMINATION OF G-GLUTAMYLTRANSPEPTIDASE | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1976-09-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210283100-A1 | ASCORBIC ACID, QUINONE COMPOUND, AND SODIUM GLUCOSE COTRANSPORTER INHIBITOR FOR TREATING CANCER | SLC5A1, SLC5A2, SLC5A6 | LTA4H 4225/4885MEN1 937/4885KMT2A 2743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.